Aveta Biomics

Aveta Biomics is a U.S.-based clinical-stage biopharmaceutical company. Utilizing an evolutionary biology-driven platform, the company has developed next-generation plant-derived combination therapies. The company has four clinical programs for head and neck cancer, brain cancer, and chronic graft-versus-host disease (cGVHD).